Hims & Hers Health Inc (NYSE: HIMS): To Buy Or Not To Buy, That Is The Question

Hims & Hers Health Inc (HIMS) concluded trading on Wednesday at a closing price of $15.51, with 7.34 million shares of worth about $113.77 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 140.47% during that period and on April 3, 2024 the price saw a gain of about 3.47%. Currently the company’s common shares owned by public are about 205.10M shares, out of which, 138.71M shares are available for trading.

Stock saw a price change of -1.96% in past 5 days and over the past one month there was a price change of 5.51%. Year-to-date (YTD), HIMS shares are showing a performance of 74.27% which increased to 56.35% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $5.65 but also hit the highest price of $17.16 during that period. The average intraday trading volume for Hims & Hers Health Inc shares is 4.63 million. The stock is currently trading 1.72% above its 20-day simple moving average (SMA20), while that difference is up 27.98% for SMA50 and it goes to 77.55% higher than SMA200.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Hims & Hers Health Inc (NYSE: HIMS) currently have 205.10M outstanding shares and institutions hold larger chunk of about 38.58% of that.

The stock has a current market capitalization of $3.32B and its 3Y-monthly beta is at 0.91. It has posted earnings per share of -$0.11 in the same period. It has Quick Ratio of 2.74 while making debt-to-equity ratio of 0.03. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for HIMS, volatility over the week remained 5.15% while standing at 5.58% over the month.

Analysts are in expectations that Hims & Hers Health Inc (HIMS) stock would likely to be making an EPS of $0.01 in the current quarter, while forecast for next quarter EPS is $0.01 and it is $0.2 for next year. For the current quarter EPS, analysts have given the company a lowest target -$0.04 which is $0.02 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -$0.05 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 204.85% while it is estimated to increase by 278.06% in next year.

Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Imperial Capital on February 28, 2024 offering an Outperform rating for the stock and assigned a target price of $16 to it. Coverage by Leerink Partners stated Hims & Hers Health Inc (HIMS) stock as a Market perform in their note to investors on February 26, 2024, suggesting a price target of $10 for the stock. On December 07, 2023, Imperial Capital Initiated their recommendations, while on July 28, 2023, TD Cowen Initiated their ratings for the stock with a price target of $11. Stock get a Neutral rating from Robert W. Baird on April 11, 2023.

Most Popular

Related Posts